Metabolic syndrome criteria and severity and carbon dioxide (CO

Male Adult Humans Female Middle Aged Aged Metabolic Syndrome / epidemiology Carbon Dioxide Cross-Sectional Studies Diet / adverse effects Risk Factors
CO2 emissions Diet Environment Glycaemia Metabolic syndrome Non-communicable diseases

Journal

Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734

Informations de publication

Date de publication:
13 Jul 2023
Historique:
received: 09 01 2023
accepted: 27 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 13 7 2023
Statut: epublish

Résumé

Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. To assess the association between MetS severity and amount of carbon dioxide (CO Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO Higher glycaemia levels were found in people with higher CO Low CO ISRCTN, ISRCTN89898870 . Registered 05 September 2013.

Sections du résumé

BACKGROUND BACKGROUND
Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet.
AIMS OBJECTIVE
To assess the association between MetS severity and amount of carbon dioxide (CO
DESIGN METHODS
Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS).
METHODS METHODS
Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO
RESULTS RESULTS
Higher glycaemia levels were found in people with higher CO
CONCLUSIONS CONCLUSIONS
Low CO
TRIAL REGISTRATION BACKGROUND
ISRCTN, ISRCTN89898870 . Registered 05 September 2013.

Identifiants

DOI: 10.1186/s12992-023-00948-3 PMID: 37443076 PMC: PMC10339536
pubmed: 37443076
doi: 10.1186/s12992-023-00948-3
pii: 10.1186/s12992-023-00948-3
pmc: PMC10339536
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50

Subventions

Organisme : Instituto de Salud Carlos III
ID : CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN)
Organisme : Instituto de Salud Carlos III
ID : Fondo de Investigación para la Salud (FIS)
Organisme : H2020 European Research Council
ID : Advanced Research Grant 2014-2019; agreement #340918

Informations de copyright

© 2023. The Author(s).

Références

BMJ Open. 2019 Feb 21;9(2):e021541
pubmed: 30796113
Prev Med. 2016 Jul;88:189-95
pubmed: 27095322
Obes Facts. 2017;10(3):238-251
pubmed: 28601864
Cell Metab. 2020 Jan 7;31(1):92-104.e5
pubmed: 31813824
Obes Rev. 2015 Jan;16(1):1-12
pubmed: 25407540
CMAJ. 2011 Oct 18;183(15):E1127-34
pubmed: 21911558
Med Sci Sports Exerc. 2014 Jul;46(7):1293-301
pubmed: 24389523
Med Sci Sports Exerc. 2000 Aug;32(8):1431-7
pubmed: 10949009
Nutrients. 2019 Apr 16;11(4):
pubmed: 30995719
Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
CMAJ. 2014 Nov 18;186(17):E649-57
pubmed: 25316904
Diabetes Care. 2019 Jan;42(Suppl 1):S46-S60
pubmed: 30559231
Diabetes Care. 2012 Nov;35(11):2402-11
pubmed: 23093685
Int J Environ Res Public Health. 2020 Feb 25;17(5):
pubmed: 32106472
JAMA. 2019 Oct 15;322(15):1486-1499
pubmed: 31613346
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13412-13417
pubmed: 29203655
Public Health Nutr. 2010 Sep;13(9):1364-72
pubmed: 20105389
Global Health. 2011 Jun 27;7:18
pubmed: 21707990
Diabetes Care. 2019 May;42(5):777-788
pubmed: 30389673
Nature. 2014 Nov 27;515(7528):518-22
pubmed: 25383533
Nutrients. 2020 Apr 07;12(4):
pubmed: 32272653
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
J Hypertens. 2013 Jul;31(7):1281-357
pubmed: 23817082
BMC Pediatr. 2014 Jul 05;14:175
pubmed: 24997634
Front Nutr. 2019 May 28;6:70
pubmed: 31231655
Int J Environ Res Public Health. 2019 Jan 24;16(3):
pubmed: 30682780
Sci Total Environ. 2023 Sep 15;891:164417
pubmed: 37236477
Environ Int. 2014 Dec;73:111-6
pubmed: 25108606
Lancet Planet Health. 2018 Oct;2(10):e451-e461
pubmed: 30318102
Am J Epidemiol. 1994 Jun 15;139(12):1197-209
pubmed: 8209878
Int J Epidemiol. 1993 Jun;22(3):512-9
pubmed: 8359969
Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):241-8
pubmed: 22305818
Nutr Metab Cardiovasc Dis. 2018 Dec;28(12):1275-1284
pubmed: 30459054
PLoS One. 2018 Jun 18;13(6):e0198974
pubmed: 29912978
Nutrients. 2019 Aug 14;11(8):
pubmed: 31416272
Adv Exp Med Biol. 2017;960:1-17
pubmed: 28585193
Pediatr Obes. 2020 Jan;15(1):e12578
pubmed: 31709781
PLoS One. 2014 Sep 02;9(9):e105056
pubmed: 25180496
Public Health Nutr. 2005 Oct;8(7):920-7
pubmed: 16277809
BMJ. 2020 Jul 15;370:m2322
pubmed: 32669369
J Am Coll Cardiol. 2013 Aug 20;62(8):697-703
pubmed: 23810877
Rev Esp Cardiol (Engl Ed). 2019 Nov;72(11):925-934
pubmed: 30287240
Lancet. 2019 Feb 2;393(10170):447-492
pubmed: 30660336
Public Health Nutr. 2018 Jun;21(8):1573-1582
pubmed: 29380717
Adv Nutr. 2019 Nov 1;10(Suppl_4):S389-S403
pubmed: 31728498
J Clin Oncol. 2018 Mar 20;36(9):875-883
pubmed: 29356607
Global Health. 2013 Feb 09;9:4
pubmed: 23394373
Int J Epidemiol. 2019 Apr 1;48(2):387-388o
pubmed: 30476123
BMC Health Serv Res. 2012 Sep 03;12:296
pubmed: 22943553
Environ Health. 2023 Jan 5;22(1):1
pubmed: 36600281
J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):365-367
pubmed: 28587579
Endocrinol Diabetes Nutr (Engl Ed). 2018 Jun - Jul;65(6):361-373
pubmed: 29803512
Nutr Rev. 2017 Jan;75(1):2-17
pubmed: 27974596
PLoS One. 2017 Jan 13;12(1):e0168148
pubmed: 28085886
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4146-51
pubmed: 27001851

Auteurs

Silvia García (S)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands & CIBEROBN, Guillem Colom Bldg, Campus, E-07122, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, 07120, Spain.

Rosario Pastor (R)

Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands & CIBEROBN, Guillem Colom Bldg, Campus, E-07122, Palma de Mallorca, Spain.
Faculty of Health Sciences, Catholic University of Avila, Avila, 05005, Spain.

Margalida Monserrat-Mesquida (M)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands & CIBEROBN, Guillem Colom Bldg, Campus, E-07122, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, 07120, Spain.

Laura Álvarez-Álvarez (L)

CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Institute of Biomedicine (IBIOMED), University of León, Leon, 24071, Spain.

María Rubín-García (M)

CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Institute of Biomedicine (IBIOMED), University of León, Leon, 24071, Spain.

Miguel Ángel Martínez-González (MÁ)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IDISNA, Pamplona, 31008, Spain.

Jordi Salas-Salvadó (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Biochemistry and Biotechnology Department. Human Nutrition Unit, Universitat Rovira i Virgili, IISPV, Hospital Universitari de Sant Joan, Reus, 43201, Spain.

Dolores Corella (D)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, 46100, Spain.

Albert Goday (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, 08003, Spain.
Departament of Medicine, Universitat Autònoma de Barcelona, Barcelona, 08003, Spain.

J Alfredo Martínez (JA)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Cardiometabolics Precision Nutrition Program, IMDEA Food, CEI UAM + CSIC, Madrid, 28049, Spain.
Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, 31008, Spain.

Ángel M Alonso-Gómez (ÁM)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Osakidetza Basque Health Service, Bioaraba Health Research Institute, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, 48013, Spain.

Julia Wärnberg (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, 29071, Spain.

Jesús Vioque (J)

Faculty of Health Sciences, Catholic University of Avila, Avila, 05005, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández (ISABIAL-UMH), Alicante, 03550, Spain.

Dora Romaguera (D)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, 07120, Spain.

José Lopez-Miranda (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, Córdoba, 14004, Spain.

Ramon Estruch (R)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, 08036, Spain.

Francisco J Tinahones (FJ)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Endocrinology, Virgen de la Victoria Hospital, University of Málaga, Málaga, 29010, Spain.

José Lapetra (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, 41013, Spain.

Lluís Serra-Majem (L)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Institute for Biomedical Research, University of Las Palmas de Gran Canaria, Las Palmas, 35016, Spain.

Blanca Riquelme-Gallego (B)

Faculty of Health Sciences, Catholic University of Avila, Avila, 05005, Spain.
Department of Preventive Medicine, University of Granada, Granada, 18071, Spain.

Xavier Pintó (X)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, 08907, Spain.

José J Gaforio (JJ)

Faculty of Health Sciences, Catholic University of Avila, Avila, 05005, Spain.
Department of Health Sciences, Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaen, Jaen, 23071, Spain.

Pilar Matía (P)

Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, 28040, Spain.

Josep Vidal (J)

Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, 08036, Spain.

Clotilde Vázquez (C)

Department of Endocrinology, Fundación Jiménez-Díaz, Madrid, 28040, Spain.

Lidia Daimiel (L)

Precision Nutrition and Obesity Program.IMDEA Food, Nutritional Control of the Epigenome Group, CEI UAM + CSIC, Madrid, 28049, Spain.

Emilio Ros (E)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Endocrinology and Nutrition, Lipid Clinic, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, Barcelona, 08036, Spain.

Carmen Sayón-Orea (C)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Navarra Institute of Public Health. Regional Health Service of Navarra, Pamplona, Spain.

Patricia Guillem-Saiz (P)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, 46100, Spain.

Cristina Valle-Hita (C)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Biochemistry and Biotechnology Department. Human Nutrition Unit, Universitat Rovira i Virgili, IISPV, Hospital Universitari de Sant Joan, Reus, 43201, Spain.

Robert Cabanes (R)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, 08003, Spain.

Itziar Abete (I)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, 31008, Spain.

Leire Goicolea-Güemez (L)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Osakidetza Basque Health Service, Bioaraba Health Research Institute, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, 48013, Spain.

Enrique Gómez-Gracia (E)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Public Health and Psychiatry, School of Medicine, Biomedical Research Institute of Malaga (IBIMA), University of Malaga, Málaga, 29010, Spain.

Cristina Tercero-Maciá (C)

Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández (ISABIAL-UMH), Alicante, 03550, Spain.
Centro Salud Raval, Elche-Alicante, 03203, Spain.

Antoni Colom (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, 07120, Spain.

Antonio García-Ríos (A)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, Córdoba, 14004, Spain.

Sara Castro-Barquero (S)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, 08036, Spain.

José C Fernández-García (JC)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Endocrinology, Virgen de la Victoria Hospital, University of Málaga, Málaga, 29010, Spain.

José Manuel Santos-Lozano (JM)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, 41013, Spain.

Juan Carlos Cenoz (JC)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Navarra Regional Health Service, Primary Health Care Services, Pamplona, Spain.

Rocío Barragán (R)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, 46100, Spain.

Nadine Khoury (N)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Biochemistry and Biotechnology Department. Human Nutrition Unit, Universitat Rovira i Virgili, IISPV, Hospital Universitari de Sant Joan, Reus, 43201, Spain.

Olga Castañer (O)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, 08003, Spain.

María Ángeles Zulet (MÁ)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, 31008, Spain.

Jessica Vaquero-Luna (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Osakidetza Basque Health Service, Bioaraba Health Research Institute, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, 48013, Spain.

Maira Bes-Rastrollo (M)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IDISNA, Pamplona, 31008, Spain.

Sara de Las Heras-Delgado (S)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Biochemistry and Biotechnology Department. Human Nutrition Unit, Universitat Rovira i Virgili, IISPV, Hospital Universitari de Sant Joan, Reus, 43201, Spain.

Ramon Ciurana (R)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), Barcelona, 08003, Spain.

Vicente Martín-Sánchez (V)

CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Institute of Biomedicine (IBIOMED), University of León, Leon, 24071, Spain.

Josep A Tur (JA)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain. pep.tur@uib.es.
Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands & CIBEROBN, Guillem Colom Bldg, Campus, E-07122, Palma de Mallorca, Spain. pep.tur@uib.es.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, 07120, Spain. pep.tur@uib.es.
ORCID: 0000-0002-6940-0761

Cristina Bouzas (C)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, 28029, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands & CIBEROBN, Guillem Colom Bldg, Campus, E-07122, Palma de Mallorca, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, 07120, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Metabolic syndrome criteria and severity and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Metabolic syndrome criteria and severity and...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Metabolic syndrome criteria and severity and...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Metabolic syndrome criteria and severity and...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Syndrome métabolique X › Metabolic syndrome criteria and severity and...
questionsmedicales.fr › Produits chimiques inorganiques › Composés de l'oxygène › Oxydes › Dioxyde de carbone › Metabolic syndrome criteria and severity and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Metabolic syndrome criteria and severity and...
questionsmedicales.fr › Phénomènes physiologiques › Alimentation et nutrition › Phénomènes physiologiques nutritionnels › Régime alimentaire › Metabolic syndrome criteria and severity and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Metabolic syndrome criteria and severity and...